Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.
Breast cancer research and treatment·2021
Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
International journal of cancer·2016
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.
Breast cancer research and treatment·2016
The Narrowing of Affordable Health Insurance Options in the United States.
The American journal of nursing·2026
Who stays, who leaves? Transitions from part-time to full-time private-sector employment among physicians in Portugal.
Health policy (Amsterdam, Netherlands)·2026
Job Demands, Job Resources, and Turnover Intention Among South Korean Probation Officers: Pathways Through Work-to-Family Conflict, Depressive Symptoms, and Job Satisfaction.
International journal of offender therapy and comparative criminology·2026
Labor unions and deaths of despair: Evidence from right-to-work laws.
Journal of health economics·2026
The Evolution of Advanced Practice Providers in California: Addressing the Legal Lacuna-Who Has the Duty of Informed Consent?
The Journal of legal medicine·2026